Can Lipitor cause hair loss? It is a question many patients ask after noticing changes to their hair following the start of atorvastatin therapy. Lipitor (atorvastatin) is one of the most widely prescribed statins in the UK, used to lower LDL cholesterol and reduce the risk of heart attack and stroke. While alopecia is listed as a possible side effect in the UK Summary of Product Characteristics, it is uncommon and the evidence for a direct causal link remains limited. This article explores what the science says, other potential causes to consider, and when to seek professional advice.

Does Lipitor (Atorvastatin) List Hair Loss as a Side Effect?

Yes — alopecia is listed as a possible side effect in the UK Summary of Product Characteristics for atorvastatin, classified as 'uncommon' or 'not known', though the vast majority of patients do not experience it.

Experiencing these side effects? Our pharmacists can help you navigate them →

Lipitor is a brand name for atorvastatin, one of the most widely prescribed medicines in the UK. It belongs to a class of drugs known as statins, which work by inhibiting an enzyme called HMG-CoA reductase. This enzyme plays a key role in the liver's production of cholesterol. By reducing cholesterol synthesis, atorvastatin helps lower low-density lipoprotein (LDL) cholesterol and reduce the risk of cardiovascular events such as heart attack and stroke.

When reviewing the UK Summary of Product Characteristics (SmPC) for atorvastatin, available via the Electronic Medicines Compendium (emc), hair loss — medically termed alopecia — is listed as a possible side effect in Section 4.8 (Undesirable effects). Depending on the specific product, alopecia is classified as either 'uncommon' (affecting between 1 in 100 and 1 in 1,000 people) or listed with a frequency described as 'not known' (meaning it cannot be estimated from available data). Patients should refer to the SmPC or patient information leaflet supplied with their specific product for the exact wording. These frequency classifications follow standard EU/UK pharmacovigilance definitions and are derived from a combination of clinical trial data and post-marketing surveillance reports.

It is important to note that the presence of a side effect in the product information does not mean it will affect every patient, or even most patients. The vast majority of people taking atorvastatin do not experience hair thinning or hair loss. However, if you have noticed changes to your hair since starting this medication, it is a legitimate concern worth discussing with your GP or pharmacist.

If you believe atorvastatin or any other medicine may be causing a side effect, you can report this directly to the Medicines and Healthcare products Regulatory Agency (MHRA) via the Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app. This helps the MHRA monitor the safety of medicines in real-world use.

What the Evidence Says About Statins and Hair Thinning

Evidence linking statins to hair loss is limited, consisting largely of case reports; no confirmed causal link exists between standard therapeutic doses of atorvastatin and clinically significant alopecia.

Not sure if this is normal? Chat with one of our pharmacists →

The scientific evidence linking statins specifically to hair loss remains limited and of low certainty. A small number of case reports and observational studies have described alopecia in patients taking various statins, including atorvastatin, simvastatin, and lovastatin. However, establishing a definitive causal relationship is challenging because hair loss is a common condition in the general population, particularly in middle-aged and older adults — the same demographic most likely to be prescribed statins.

One proposed biological mechanism involves the role of cholesterol in hair follicle function. Cholesterol is a component of cell membranes and is involved in the signalling pathways that regulate the hair growth cycle. Some researchers have theorised that significant reductions in cholesterol availability could potentially disrupt the anagen (growth) phase of the hair cycle, leading to increased shedding. This mechanism remains hypothetical and has not been conclusively demonstrated in human studies. There is no confirmed causal link between standard therapeutic doses of atorvastatin and clinically significant hair loss.

Reviews of drug-induced alopecia in the dermatological literature note that statin-related hair loss, if it does occur, is typically:

• Diffuse rather than patchy

• Gradual in onset, often appearing weeks to months after starting treatment

• Reversible upon discontinuation of the causative drug in most reported cases

Overall, the evidence base consists largely of case reports and observational data, and causality remains unproven. It is also worth considering that the stress of a new diagnosis (such as high cholesterol or cardiovascular disease), or concurrent lifestyle and dietary changes, may independently contribute to hair shedding — a condition known as telogen effluvium. Attributing hair loss solely to a medication without proper clinical assessment can therefore be misleading.

Other Medicines and Conditions That Can Cause Hair Loss

Many medicines — including beta-blockers, anticoagulants, and antithyroid drugs — and conditions such as hypothyroidism and iron deficiency anaemia are well-established causes of hair loss that must be excluded before blaming atorvastatin.

Before attributing hair loss to atorvastatin, it is essential to consider the wide range of other medicines and underlying health conditions that are well-established causes of alopecia. Hair loss is a multifactorial condition, and in many cases a thorough clinical assessment will reveal an alternative or contributing explanation.

Medicines commonly associated with hair loss include:

• Anticoagulants such as warfarin and heparin

• Antithyroid drugs (e.g., carbimazole)

• Antidepressants, including some SSRIs

• Beta-blockers (e.g., propranolol, bisoprolol)

• Hormonal contraceptives, particularly those with high androgenic activity

• Retinoids used for skin conditions

• Certain antifungal agents (e.g., terbinafine has been associated with hair loss in case reports)

Underlying medical conditions that frequently cause hair thinning include:

• Androgenetic alopecia — the most common cause of progressive hair loss in both men and women (male and female pattern hair loss)

• Hypothyroidism or hyperthyroidism — thyroid dysfunction is one of the most common reversible causes of diffuse hair loss

• Iron deficiency anaemia — particularly prevalent in women of reproductive age

• Alopecia areata — an autoimmune condition causing patchy hair loss

• Polycystic ovary syndrome (PCOS) — associated with androgenic alopecia in women

• Tinea capitis — a fungal scalp infection that can cause patchy hair loss, particularly in children

• Telogen effluvium — triggered by physical or emotional stress, illness, surgery, or significant weight loss

• Nutritional deficiencies — including iron deficiency; other deficiencies (such as zinc, biotin, or vitamin D) are less commonly a cause and should only be investigated if clinically suspected, not routinely

Given this broad differential, NICE Clinical Knowledge Summaries (CKS) on diffuse hair loss, alopecia areata, and female pattern hair loss recommend a structured assessment approach that includes a detailed medication history, targeted blood tests to exclude systemic causes, and a scalp examination. It would therefore be premature to conclude that atorvastatin is the cause of hair loss without ruling out these other possibilities first. The British Association of Dermatologists (BAD) also provides patient information on various forms of alopecia, which may be a helpful resource.

When to Speak to Your GP or Pharmacist

Consult your GP if hair loss is noticeable, progressive, or accompanied by systemic symptoms; do not stop atorvastatin independently, as this carries significant cardiovascular risk.

If you have noticed increased hair shedding, thinning, or bald patches since starting atorvastatin or any other new medication, it is advisable to seek professional advice rather than stopping your treatment independently. Statins are prescribed for important cardiovascular reasons, and discontinuing them without guidance could carry significant health risks.

You should contact your GP if:

• Hair loss is noticeable, progressive, or causing you distress

• You have developed patchy or sudden hair loss, which may suggest alopecia areata

• Hair loss is accompanied by other symptoms such as fatigue, weight changes, or feeling cold — which could indicate a thyroid problem

• You have recently started or changed any medication

• Hair loss persists for more than two to three months

Seek prompt assessment (same week or sooner) if you notice:

• Scalp pain, redness, scaling, or pustules alongside hair loss — these may suggest a scalp infection (such as tinea capitis) or a scarring alopecia (such as lichen planopilaris or discoid lupus erythematosus), which require early specialist review

• Rapid or widespread hair loss associated with systemic symptoms

Your GP may arrange blood tests to check thyroid function, full blood count, and ferritin (iron stores). Further tests — such as vitamin B12, zinc, or vitamin D — are not routine and should only be requested if there is a specific clinical reason to suspect deficiency. Your GP may refer you to a dermatologist if the cause remains unclear or if specialist assessment is needed.

Your community pharmacist is also an excellent first point of contact. They can review your full medication list, identify potential drug-related causes, and advise whether it is appropriate to continue your current treatment while awaiting a GP appointment.

Importantly, do not stop taking atorvastatin without speaking to a healthcare professional first. The cardiovascular benefits of statin therapy are well-evidenced and, for most patients, significantly outweigh the risk of rare side effects such as hair thinning.

Managing Side Effects While Staying on Your Prescribed Treatment

If atorvastatin is suspected to cause hair loss, switching to a different statin or adjusting the dose are practical options a GP can explore while maintaining cardiovascular protection.

If your GP or pharmacist suspects that atorvastatin may be contributing to hair loss, there are several practical approaches that can be considered without necessarily abandoning statin therapy altogether. The goal is always to balance the management of side effects with the continuation of effective cardiovascular protection.

One option your doctor may consider is switching to a different statin. There are several statins available in the UK, including rosuvastatin, simvastatin, pravastatin, and fluvastatin. Because statins differ in their chemical structure, lipophilicity, and metabolic pathways, a patient who experiences a side effect with one statin may tolerate another better. Your doctor may also consider dose reduction or alternate-day dosing as strategies to manage tolerability, depending on your individual cardiovascular risk. In some circumstances, where statin therapy is not tolerated, alternative lipid-lowering agents — such as ezetimibe, bempedoic acid, or, in high-risk patients, PCSK9 inhibitors — may be considered. These decisions should be guided by your GP or specialist in line with current NICE guidance on cardiovascular disease risk assessment and lipid modification (NICE NG238, 2023).

In parallel, addressing any nutritional deficiencies identified through blood tests can support hair regrowth. Supplementation should only be considered if a deficiency has been confirmed by testing; routine supplementation with zinc, biotin, or vitamin D is not recommended in the absence of a confirmed deficiency.

General hair care advice during this period includes:

• Avoiding excessive heat styling or chemical treatments

• Using gentle shampoos suited to your hair type

• Avoiding tight hairstyles that place tension on the scalp

• Eating a balanced diet rich in protein, leafy vegetables, and healthy fats

If drug-induced alopecia is confirmed and hair loss is significantly affecting your quality of life, your GP may refer you to a dermatologist for further assessment. Treatment options will depend on the underlying cause; for example, topical minoxidil is licensed for androgenetic alopecia and may be considered by a clinician in appropriate cases — it should not be started without professional advice. In most reported cases of statin-related hair loss, the condition is reversible once the causative agent is identified and addressed. With the right support, it is usually possible to manage this concern effectively while maintaining the cardiovascular benefits of your prescribed treatment.

Frequently Asked Questions